Print Settings
 

BIOE 273: Biodesign for Digital Health (MED 273)

Health care is facing significant cross-industry challenges and opportunities created by a number of factors, including the increasing need for improved access to affordable, high-quality care; growing demand from consumers for greater control of their health and health data; the shift in focus from sick care to prevention and health optimization; aging demographics and the increased burden of chronic conditions; and new emphasis on real-world, measurable health outcomes for individuals and populations. Moreover, the delivery of health information and services is no longer tied to traditional brick and mortar hospitals and clinics: it has increasingly become "mobile," enabled by apps, sensors, wearables. Simultaneously, it has been augmented and often revolutionized by emerging digital and information technologies, as well as by the data that these technologies generate. This multifactorial transformation presents opportunities for innovation across the entire cycle of care, from wellness, to acute and chronic diseases, to care at the end of life. But how does one approach innovation in digital health to address these health care challenges while ensuring the greatest chance of success? At Stanford Biodesign, we believe that innovation is a process that can be learned, practiced, and perfected; and, it starts with an unmet need. In Biodesign for Digital Health, students will learn about digital health and the Biodesign needs-driven innovation process from over 50 industry experts. Over the course of 10weeks, these speakers will join the teaching team in a dynamic classroom environment that includes lectures, panel discussions, and breakout sessions. These experts represent startups, corporations, venture capital firms, accelerators, research labs, healthcare providers, and more. Student teams will take actual digital and mobile health challenges and learn how to apply Biodesign innovation principles to research and evaluate needs, ideate solutions, and objectively assess them against key criteria for satisfying the needs. Teams take a hands-on approach with the support of need coaches and other mentors. On the final day of class, teams present to a panel of digital health experts and compete for project extension funding. Friday section will be used for team projects and for scheduled workshops. Limited enrollment for this course. Students should submit their application online via: https://stanforduniversity.qualtrics.com/jfe/form/SV_dnY6nvUXMYeILkO
Terms: Aut | Units: 3-4

BIOE 374A: Biodesign Innovation: Needs Finding and Concept Creation (ME 368A, MED 272A)

In this two-quarter course series ( BIOE 374A/B, MED 272A/B, ME 368A/B, OIT 384/5), multidisciplinary student teams identify real-world unmet healthcare needs, invent new health technologies to address them, and plan for their implementation into patient care. During the first quarter (winter), students select and characterize an important unmet healthcare problem, validate it through primary interviews and secondary research, and then brainstorm and screen initial technology-based solutions. In the second quarter (spring), teams select a lead solution and move it toward the market through prototyping, technical re-risking, strategies to address healthcare-specific requirements (regulation, reimbursement), and business planning. Final presentations in winter and spring are made to a panel of prominent health technology experts and/or investors. Class sessions include faculty-led instruction and case studies, coaching sessions by industry specialists, expert guest lecturers, and interactive team meetings. Enrollment is by application only, and students are required to participate in both quarters of the course. Visit http://biodesign.stanford.edu/programs/stanford-courses/biodesign-innovation.html to access the application, examples of past projects, and student testimonials. More information about Stanford Biodesign, which has led to the creation of 50 venture-backed healthcare companies and has helped hundreds of student launch health technology careers, can be found at http://biodesign.stanford.edu/.
Terms: Win | Units: 4

BIOE 393: Bioengineering Departmental Research Colloquium

Bioengineering department labs at Stanford present recent research projects and results. Guest lecturers. Topics include applications of engineering to biology, medicine, biotechnology, and medical technology, including biodesign and devices, molecular and cellular engineering, regenerative medicine and tissue engineering, biomedical imaging, and biomedical computation.
Terms: Aut | Units: 1 | Repeatable for credit

BIOMEDIN 215: Data Science for Medicine

The widespread adoption of electronic health records (EHRs) has created a new source of big data namely, the record of routine clinical practice as a by-product of care. This graduate class will teach you how to use EHRs and other patient data to discover new clinical knowledge and improve healthcare. Upon completing this course, you should be able to: differentiate between and give examples of categories of research questions and the study designs used to address them, describe common healthcare data sources and their relative advantages and limitations, extract and transform various kinds of clinical data to create analysis-ready datasets, design and execute an analysis of a clinical dataset based on your familiarity with the workings, applicability, and limitations of common statistical methods, evaluate and criticize published research using your knowledge of 1-4 to generate new research ideas and separate hype from reality. Prerequisites: CS 106A or equivalent, STATS 60 or equivalent. Recommended: STATS 216, CS 145, STATS 305NOTE: For students in the Department of Biomedical Data Science Program, this core course MUST be taken as a letter grade only.
Terms: Aut | Units: 3

BIOMEDIN 256: Economics of Health and Medical Care (BIOMEDIN 156, ECON 126, HRP 256)

Institutional, theoretical, and empirical analysis of the problems of health and medical care. Topics: demand for medical care and medical insurance; institutions in the health sector; economics of information applied to the market for health insurance and for health care; economics of health care labor markets and health care production; and economic epidemiology. Graduate students with research interests should take ECON 249. Prerequisites: ECON 50 and either ECON 102A or STATS 116 or the equivalent. Recommended: ECON 51.
Terms: Spr | Units: 5

CSB 242: Drug Discovery and Development Seminar Series

The scientific principles and technologies involved in making the transition from a basic biological observation to the creation of a new drug emphasizing molecular and genetic issues. Prerequisite: biochemistry, chemistry, or bioengineering.
Terms: Aut, Win, Spr | Units: 1 | Repeatable 2 times (up to 2 units total)

CSB 245: Economics of Biotechnology

Focuses on translation of promising research discovery into marketed drugs and the integration of scientific method, clinical needs assessment, clinical and regulatory strategy, market analysis, economic considerations, and the influence of the healthcare economic ecosystem necessary for successful translation. Explores the economic perspectives of various stakeholders--patients, providers, payers, biotechnology and pharmaceutical companies, FDA, and financial markets--and how they influence drug development.
Terms: Spr | Units: 2

EASTASN 117: Health and Healthcare Systems in East Asia (EASTASN 217)

This course will discuss population health and healthcare systems in contemporary China, Japan, and Korea (north and south), in comparative perspective with other health systems. Using primarily the lens of social science, especially health economics, we will analyze recent developments in East Asian health policy, in comparison to other health systems of the world. Topics include the social determinants of health, demographic transition and population aging, control of infectious and chronic non-communicable diseases, healthcare financing, health insurance, health service delivery, payment incentives, competition, pharmaceutical policy, long-term care, and regulation. Although some background in Asian Studies, economics, and/or global health will be useful, no prior knowledge of economics or health policy is expected or required.
Terms: Win | Units: 3-5
Instructors: ; Eggleston, K. (PI)

EDUC 335: Designing Research-Based Interventions to Solve Global Health Problems (AFRICAST 135, AFRICAST 235, EDUC 135, EPI 235, HUMBIO 26, MED 235)

The excitement around social innovation and entrepreneurship has spawned numerous startups focused on tackling world problems, particularly in the fields of education and health. The best social ventures are launched with careful consideration paid to research, design, and efficacy. This course offers students an immersive educational experience into understanding how to effectively develop, evaluate, and scale social ventures. Students will also get a rare "behind-the-scenes" glimpse at the complex ethical dilemmas social entrepreneurs have tackled to navigate the odds. Partnered with TeachAids, a global award-winning nonprofit (scaled to 82 countries), this course introduces students to the major principles of research-based design and integrates instruction supported by several game-changing social leaders. Open to both undergraduate and graduate students, it culminates in a formal presentation to an interdisciplinary panel of diverse Silicon Valley leaders. (Cardinal Course certified by the Haas Center)
Terms: Win | Units: 3

FAMMED 245: Women and Health Lecture Series

Lecture series. Topics of interest to anyone concerned about women's health issues. A journey from sex and gender through health screening, health disparity, family planning, heart health, mental health, and even beyond women's health in considering trans and gender expansive people in sexual and reproductive health.
Terms: Aut | Units: 1
Instructors: ; Romalis, D. (PI)

GSBGEN 503: The Business of Healthcare

Healthcare spending is now nearly 18% of the entire GDP of the U.S. economy. The S&P healthcare sector has been one of the best producing segments of the market for the last decade, and growth of healthcare expenditures continue to escalate at a rapid pace. Given the experiences of COVID, every single company must now at least understand how healthcare affects their business. This has triggered an abundance of opportunities for those interested in a career in healthcare management, investing, or entrepreneurialism. The Business of Healthcare-2022-23 will present the current market framework from the eyes of a clinician and with the perspective of the consumer-patient, but with the experience of a successful business builder and investor. Course will begin with the discussion of the channels of distribution of healthcare delivery, from providers, to practitioners, to consumer-facing 'healthcare lite' sectors of the market. Impact of the regulatory environment, with specific focus on the Affordable Care Act and the impending plans to Repeal/Replace, will be evaluated. High-level exploration of international health care markets and how they compare to the American market will be included. Overview of venture and private equity investing will be deeply probed, with many specific market examples of how investors develop an investment thesis, identify specific targets, diligence companies, and close an investment. Discussion around building financial modeling for target acquisitions will be presented, and the course will delve into the burgeoning area of healthcare analytics and outcomes management, including Artificial Intelligence, and its future impact on positioning, reimbursement and clinical outcomes, as well as value-based care. Sectors that will be discussed include: Healthcare services, Healthcare IT, Life Sciences, Pharma and Biotechnology, and Managed Care. The topic of the emerging importance of consumerism will be probed and consumer-directed healthcare related products and services will be explored, e.g. nutraceuticals, wellness, fitness, etc. Course will include preparatory readings, presentations from successful and powerful industry leaders, and robust in-class discussion and case studies requiring student engagement. Final grade will consist of class participation, one minor in-class presentation, and a final paper developing either a new healthcare business start-up proposition or presenting an identified investment target in the healthcare industry. Course will be especially valuable for those interested in a career in starting a healthcare company, healthcare investing, healthcare administration, or other healthcare-related management and goal of class will be provide an in-depth overview of how to get started or advance a professional interest in the industry.
Terms: Win | Units: 2

GSBGEN 551: Innovation and Management in Health Care

The health care system accounts for almost 20% US GDP and is one of the fastest growing segments of the economy. This two unit class focuses on the interplay and tension between the main players in the health care field - providers of health care services (individual doctors, group practices, integrated health care systems), payors (insurances companies, employers, consumers, and government), patients, and innovator companies (biopharma, medical device, diagnostics, and health care IT). The course is designed for students with a broad diversity of backgrounds and interests who want to better understand the health care business and system. No prior experience in the health care or medical field is assumed or needed. The focus of the class will be primarily on the US health care system, but there will be limited discussion of non-US systems as well. The course is divided into four modules:¿ An overview of the US Health Care System and the interplay between payers, providers, innovators, and patients¿ Provider delivery models, health care information technology, and incentive structures- The relationship between quality, cost, and access- Integrated systems, value-based, and fee for service models- New IT technologies, including electronic data records- The role of information and incentives¿ Innovator business models and issues- Financing and managing new product development- Clinical trial management and gaining regulatory approval- Marketing, reimbursement, and sales strategies- Business models to drive innovation ¿ Health care system reform and comparisons of the structure of the US Health Care system to that of other countries. The class will be taught primarily from the perspective of a business person operating a company rather than that of a policy maker, academic, or investor. While there will be a few lectures to provide background and frameworks for course topics, most classes will involve a case discussion and prominent guest speakers from the health care industry. Speakers will include CEOs, senior executives, and partners from leading companies and venture firms.
Terms: Win | Units: 2
Instructors: ; Chess, R. (PI); Davis, S. (GP)

HRP 211: Law and Biosciences: Neuroscience

(Same as LAW 3006) Legal, social, and ethical issues arising from advances in neuroscience, including effects upon law and society through improvements in predicting illnesses and behaviors, reading minds through neuroimaging, understanding responsibility and consciousness, treating criminal behavior, and cognitive enhancement.
Terms: Win | Units: 3
Instructors: ; Greely, H. (PI)

HRP 391: Health Law: Finance and Insurance

(SAME AS LAW 3001, MGTECON 331) This course provides the legal, institutional, and economic background necessary to understand the financing and production of health services in the U.S. We will discuss the Affordable Care Act , health insurance (Medicare and Medicaid, employer-sponsored insurance, the uninsured), the approval process and IP protection for pharmaceuticals, and antitrust policy. We may discuss obesity and wellness, regulation of fraud and abuse, and medical malpractice. The syllabus for this course can be found at https://syllabus.stanford.edu. Elements used in grading: Participation, attendance, class presentation, and final exam.
Terms: Win | Units: 3

HUMBIO 128: Community Health Psychology (PSYCH 101)

Social ecological perspective on health emphasizing how individual health behavior is shaped by social forces. Topics include: biobehavioral factors in health; health behavior change; community health promotion; and psychological aspects of illness, patient care, and chronic disease management. Prerequisites: HUMBIO 3B or PSYCH 1 or consent of the instructor
Terms: Win | Units: 4 | UG Reqs: WAY-SI
Instructors: ; Heaney, C. (PI)

HUMBIO 130: Human Nutrition (CHPR 130)

The study of food, and the nutrients and substances therein. Their action, interaction, and balance in relation to health and disease. Emphasis is on the biological, chemical, and physiological processes by which humans ingest, digest, absorb, transport, utilize, and excrete food. Dietary composition and individual choices are discussed in relationship to the food supply, and to population and cultural, race, ethnic, religious, and social economic diversity. The relationships between nutrition and disease; ethnic diets; vegetarianism; nutritional deficiencies; nutritional supplementation; phytochemicals. The material in this course is an introduction to the field and the target audience is undergraduates. It may be of interest to graduate students unfamiliar with the field. Graduate students enroll in CHPR 130. Undergrads enroll in HUMBIO 130. CHPR master's students must enroll for a letter grade.
Terms: Spr | Units: 4 | UG Reqs: WAY-SMA
Instructors: ; Gardner, C. (PI)

HUMBIO 151R: Biology, Health and Big Data

We are living in a time of rapid growth in the accessibility and availability of biological and medical data. How can all this data be used to improve human health? In this course, students will look at case studies from diabetes and cancer research to learn how to access publicly available data ranging from genetic, protein and signaling pathway databases to information about clinical trials. Students will apply what they learn about bioinformatics databases to develop a research proposal and presentation on a biology-related topic of their choice. The class will have an interactive format with in-class data analysis activities. Students will gain skills in research methods including accessing, analyzing and presenting data. Assignments will use the R programming language. Prior programming experience is not required. Prerequisites: HUMBIO 2A and HUMBIO 3A or BIO 82 and BIO 83 or consent of instructor
Terms: Spr | Units: 3 | UG Reqs: WAY-SMA
Instructors: ; Salmeen, A. (PI)

HUMBIO 154C: Cancer Epidemiology

Clinical epidemiological methods relevant to human research in cancer will be the focus. The concepts of risk; case control, cohort, and cross-sectional studies; clinical trials; bias; confounding; interaction; screening; and causal inference will be introduced and applied. Social, political, economic, and ethical controversies surrounding cancer screening, prevention, and research will be considered. HUMBIO 154 courses can be taken separately or as a series. Prerequisites: Human Biology core or Biology Foundations or instructor consent.
Terms: Win | Units: 4 | UG Reqs: WAY-AQR
Instructors: ; Fisher, P. (PI); Chen, C. (TA)

ME 206A: Design for Extreme Affordability

Design for Extreme Affordability (fondly called Extreme) is a two-quarter course offered by the d.school through the School of Engineering and the Graduate School of Business. This multidisciplinary project-based experience creates an enabling environment in which students learn to design products and services that will change the lives of the world's poorest citizens. Students work directly with course partners on real world problems, the culmination of which is actual implementation and real impact. Topics include design thinking, product and service design, rapid prototype engineering and testing, business modelling, social entrepreneurship, team dynamics, impact measurement, operations planning and ethics. Possibility to travel overseas during spring break. Previous projects include d.light, Driptech, Earthenable, Embrace, the Lotus Pump, MiracleBrace, Noora Health and Sanku. Periodic design reviews; Final course presentation and expo; industry and adviser interaction. Limited enrollment via application. Must sign up for ME206A and ME206B. See extreme.stanford.edu
Terms: Win | Units: 4

ME 206B: Design for Extreme Affordability

Design for Extreme Affordability (fondly called Extreme) is a two-quarter course offered by the d.school through the School of Engineering and the Graduate School of Business. This multidisciplinary project-based experience creates an enabling environment in which students learn to design products and services that will change the lives of the world's poorest citizens. Students work directly with course partners on real world problems, the culmination of which is actual implementation and real impact. Topics include design thinking, product and service design, rapid prototype engineering and testing, business modelling, social entrepreneurship, team dynamics, impact measurement, operations planning and ethics. Possibility to travel overseas during spring break. Previous projects include d.light, Driptech, Earthenable, Embrace, the Lotus Pump, MiracleBrace, Noora Health and Sanku. Periodic design reviews; Final course presentation and expo; industry and adviser interaction. Limited enrollment via application. Must sign up for ME206A and ME206B. See extreme.stanford.edu. Cardinal Course certified by the Haas Center
Terms: Spr | Units: 4

ME 368B: Biodesign Innovation: Concept Development and Implementation (BIOE 374B, MED 272B)

In this two-quarter course, multidisciplinary teams identify real unmet healthcare needs, invent health technologies to address them, and plan for their implementation into patient care. In second quarter, teams select a lead solution to advance through technical prototyping, strategies to address healthcare-specific requirements (IP, regulation, reimbursement), and business planning. Class sessions include faculty-led instruction, case studies, coaching sessions by experts, guest lecturers, and interactive team meetings. Enrollment is by application. Students are required to take both quarters of the course.
Terms: Spr | Units: 4 | Repeatable 2 times (up to 8 units total)

MED 157: Foundations for Community Health Engagement

Open to undergraduate, graduate, and MD students. Examination and exploration of community health principles and their application at the local level. Designed to prepare students to make substantive contributions in a variety of community health settings (e.g. clinics, government agencies, non-profit organization, advocacy groups). Topics include community health assessment; health disparities; health promotion and disease prevention; strategies for working with diverse, low-income, and underserved populations; and principles of ethical and effective community engagement.
Terms: Spr | Units: 3 | UG Reqs: WAY-EDP, WAY-SI
Instructors: ; Heaney, C. (PI)

MED 200: Primary Care Presentations

This course is a lecture series offered during the winter quarter. The aim of this seminar is to allow medical students to experience the mindset of primary care physicians in real time. Classes feature presentations of patient cases submitted by Stanford faculty. Faculty presenters are provided with the diagnostic information for the cases in a sequential manner during and not in advance of each class, allowing students to learn from the thought process of physicians in real time as they put together the differential diagnosis, interpret diagnostic information, deliberate treatment and management options, and discuss other thoughts about the cases.
Terms: Win | Units: 1

MED 232: Global Health: Scaling Health Technology Innovations in Low Resource Settings

Recent advances in health technologies - incorporating innovations like robotics, cloud computing, artificial intelligence, and smart sensors - have raised expectations of a dramatic impact on health outcomes across the world. However, bringing innovative technologies to low-resource settings has proven challenging, limiting their impact. Ironically, the COVID-19 pandemic became Exhibit 1 in the challenges the global health community faces in scaling innovative interventions. This course explores critical questions regarding the implementation and impact of technological innovations in low-resource settings. The course will feature thought leaders from the health technology community, who will explore examples of technologies that have been successful in low-resource communities, as well as those that have failed. A subset of these examples will be drawn from the current pandemic. Students will think critically to consider conditions under which technologies reach scale and have a positive impact on the global health field. Students will also have an opportunity to work on real-world projects, each of which will focus on the potential opportunity for health technology in a low-resource setting and consider approaches to ensure its impact at scale. This course will be taught by Dr. Anurag Mairal, Adjunct Professor of Medicine and the Director, Global Outreach Programs at Stanford Byers Center for Biodesign, Dr. Krista Donaldson, Director of Innovation to Impact at Stanford Byers Center for Biodesign, and Dr. Michele Barry, Senior Associate Dean for Global Health and Director of the Center for Innovation in Global Health. This course is open to undergraduate students, graduate students, and medical students. Students can take the course for two or three units. Students enrolling in the course for a third unit will work on the group project described above. Students enrolled in the class for three units will also have additional assignments, including an outline, presentation, and paper related to the group project. Cardinal Course certified by the Haas Center. Questions can be directed to Course Manager, Yosefa Gilon, ygilon@stanford.edu. Students must submit an application and be selected to receive an enrollment code. Application - https://forms.gle/WfToKFonCXWc6wZL7
Terms: Win | Units: 2-3 | Repeatable for credit

MED 233: Global Health: Beyond Diseases and International Organizations

Provides multidisciplinary trainees insight into over-arching themes of global health. Topics include systemic issues affecting healthcare progress globally, ethical and thoughtful approaches to solving these issues, as well as economics, water sanitation, public health, organizations in global health, human rights, involvement in NGOs, ethics of overseas work, and other non-medical aspects of this subject. This course will cover some of the essentials of patient care while working in the field as well including child health care, malaria, TB, and HIV. The course is only open to graduate students and MD/MSPA/PhD students and faculty (of any discipline). Students must submit an application and be selected to receive an enrollment code. The application form can be found at the following link: https://forms.gle/dYfkzmWFUiEgfz9D6
Terms: Spr | Units: 4

MED 242: Human Rights and Health

Weekly lectures on how human rights violations affect health. Topics include: regional conflict and health, the health status of refugees and internally displaced persons; child labor; trafficking in women and children; HIV/AIDS; torture; poverty, the environment and health; access to clean water; domestic violence and sexual assault; and international availability of drugs. Guest speakers from national and international NGOs including Doctors Without Borders; McMaster University Institute for Peace Studies; UC Berkeley Human Rights Center; Kiva.
Terms: Win | Units: 1

MED 294: Critical Issues in Global Health (MED 194)

In this course, participants will discuss and engage critically with current topics and pressing issues in global health through the lens of health equity and social justice. Topics include decolonizing global health, climate change, the health of indigenous populations, and other vulnerable populations, homelessness, and gender-based violence and mental health challenges. Students will hear from and engage with experts in the field and debate critical issues in global health through course discussions. Three-unit students will investigate a global health equity challenge and present recommendations for effective interventions. Speakers represent a range of voices and perspectives. They include: Dr. Madhu Pai, a global health leader, health equity advocate, and tuberculosis expert; Dr. Jim O'Connell, a Boston physician who has dedicated his career to caring for people living on the streets; Dr. Agnes Binagwaho, retired Vice Chancellor of the University of Global Health Equity in Rwanda to name a few. Participants will gain new insights into the health equity considerations critical to addressing contemporary challenges, explore diverse perspectives on key issues, and critically consider current and potential interventions through the lens of a global health practitioner. Requirements for the course include attendance and participation in class discussions, a short capstone presentation, and a final paper. This course will be taught by Dean Michele Barry Director of the Center for Innovation in Global Health, and Dr. Geoffrey Tabin, Professor of Ophthalmology and Global Medicine and co-founder of the internationally renowned Himalayan Cataract Project. Course enrollment is open to medical students, graduate students, and undergraduate students (2-3 Units). This course must be taken for a minimum of 3 units and a letter grade to be eligible for Ways credit.
Terms: Spr | Units: 2-3 | Repeatable 3 times (up to 9 units total)

MGTECON 331: Health Law: Finance and Insurance

This course provides the legal, institutional, and economic background necessary to understand the financing and production of health services in the US. Potential topics include: health reform, health insurance (Medicare and Medicaid, employer-sponsored insurance, the uninsured), medical malpractice and quality regulation, pharmaceuticals, the corporate practice of medicine, regulation of fraud and abuse, and international comparisons.
Terms: Win | Units: 3

MS&E 256: Technology Assessment and Regulation of Medical Devices (BIOE 256)

Regulatory approval and reimbursement for new health technologies are critical success factors for product commercialization. This course explores the regulatory and payer environment in the U.S. and abroad, as well as common methods of health technology assessment. Students will learn frameworks to identify factors relevant to the adoption of new health technologies, and the management of those factors in the design and development phases of bringing a product to market through case studies, guest speakers from government (FDA) and industry, and a course project.
Terms: Spr | Units: 3

MS&E 256A: Technology Assessment and Regulation of Medical Devices

Regulatory approval and reimbursement for new medical technologies as a key component of product commercialization. The regulatory and payer environment in the U.S. and abroad, and common methods of health technology assessment. Framework to identify factors relevant to adoption of new medical devices, and the management of those factors in the design and development phases. Case studies; guest speakers from government (FDA) and industry.
Terms: Spr | Units: 1

MS&E 263: Healthcare Operations Management

US health care spending is approximately 18% of GDP, growing rapidly, and driven in large part by prices and waste rather than quality and access. New approaches for improving health care delivery are urgently needed. This class focuses on the use of analytical tools to support efficient health care delivery. Topics include case studies on capacity planning, resource allocation, and scheduling. Methods include queueing, optimization, and simulation. Prerequisites: basic knowledge of Excel, probability, and optimization. For students in the Schools of Medicine, Business, and Law the course includes a variant of the curriculum with less emphasis on the technical material.
Terms: Win | Units: 3

MS&E 292: Health Policy Modeling (HRP 293)

Primarily for master's students; also open to undergraduates and doctoral students. The application of mathematical, statistical, economic, and systems models to problems in health policy. Areas include: disease screening, prevention, and treatment; assessment of new technologies; bioterrorism response; and drug control policies.
Terms: Win | Units: 3

OBGYN 216: Current Issues in Reproductive Health

Reproductive Health is a broad subject encompassing many concepts and practices. Issues and services within the context of reproductive health include such diverse topics as fertility, pregnancy, contraception, abortion, sexuality, menopause and parenting. Course focuses on topics related to abortion services, fertility and contraception; current research and practices in family planning; legislation and issues of access.
Terms: Win | Units: 1 | Repeatable for credit

OIT 333: Design for Extreme Affordability

Design for Extreme Affordability (Extreme) is for students who have a passion for social impact, and want to experience designing products and services that address issues of global poverty, through tackling real world challenges in collaboration with low-resource communities. Extreme is a two-quarter graduate level sequence cross listed by the Graduate School of Business (OIT333/334) and the School of Engineering (ME206A/B). The program is hosted by the d.school and open to students from all Stanford schools. This multidisciplinary team, fast paced, project based experience creates an enabling environment in which students learn to design products and services that will change the lives of the world's poorest citizens. Students work directly with course partners, and the communities they serve, on real world problems, the culmination of which is actual implementation and real impact. Topics include design thinking, product and service design, rapid prototype engineering and testing, business modeling, social entrepreneurship, team dynamics, impact measurement, operations planning and ethics. Products and services designed in the class have impacted well over 150 million people worldwide. Limited enrollment by application. Must sign up for both OIT333/ME206A (Winter) and OIT334/ME206B (Spring). See extreme.stanford.edu for more details and application process which opens in October. Cardinal Course certified by the Haas Center for Public Service.
Terms: Win | Units: 4

OIT 334: Design for Extreme Affordability

Design for Extreme Affordability ('Extreme') is for students who have a passion for social impact, and want to experience designing products and services that address issues of global poverty, through tackling real world challenges in collaboration with low-resource communities. Extreme is a two-quarter graduate level sequence cross listed by the Graduate School of Business (OIT333/334) and the School of Engineering (ME206A/B). The program is hosted by the d.school and open to students from all Stanford schools. This multidisciplinary team, fast paced, project based experience creates an enabling environment in which students learn to design products and services that will change the lives of the world's poorest citizens. Students work directly with course partners, and the communities they serve, on real world problems, the culmination of which is actual implementation and real impact. Topics include design thinking, product and service design, rapid prototype engineering and testing, business modeling, social entrepreneurship, team dynamics, impact measurement, operations planning and ethics. Products and services designed in the class have impacted well over 150 million people worldwide.Limited enrollment by application. Must sign up for both OIT333/ME206A (Winter) and OIT334/ME206B (Spring).See extreme.stanford.edu for more details and application process which opens in October.Cardinal Course certified by the Haas Center for Public Service.
Terms: Spr | Units: 4

OIT 384: Biodesign Innovation: Needs Finding and Concept Creation

In this two-quarter course series (OIT 384/5), multidisciplinary student teams from medicine, business, and engineering work together to identify real-world unmet healthcare needs, invent new health technologies to address them, and plan for their development and implementation into patient care. During the first quarter (winter), students select and characterize an important unmet healthcare problem, validate it through primary interviews and secondary research, and then brainstorm and screen initial technology-based solutions. In the second quarter (spring), teams screen their ideas, select a lead solution, and move it toward the market through prototyping, technical re-risking, strategies to address healthcare-specific requirements (regulation, reimbursement), and business planning. Final presentations in winter and spring are made to a panel of prominent health technology industry experts and investors. Class sessions include faculty-led instruction and case studies, coaching sessions by industry specialists, expert guest lecturers, and interactive team meetings. Enrollment is by application only, and students are expected to participate in both quarters of the course. Visit http://biodesign.stanford.edu/programs/stanford-courses/biodesign-innovation.html to access the application, examples of past projects, and student testimonials. More information about Stanford Biodesign, which has led to the creation of more than 50 venture-backed healthcare companies and has helped hundreds of students launch health technology careers, can be found at http://biodesign.stanford.edu/.
Terms: Win | Units: 4

OIT 385: Biodesign Innovation: Concept Development and Implementation

In this two-quarter course series (OIT 384/5), multidisciplinary student teams from medicine, business, and engineering work together to identify real-world unmet healthcare needs, invent new health technologies to address them, and plan for their development and implementation into patient care. During the first quarter (winter), students select and characterize an important unmet healthcare problem, validate it through primary interviews and secondary research, and then brainstorm and screen initial technology-based solutions. In the second quarter (spring), teams screen their ideas, select a lead solution, and move it toward the market through prototyping, technical re-risking, strategies to address healthcare-specific requirements (regulation, reimbursement), and business planning. Final presentations in winter and spring are made to a panel of prominent health technology industry experts and investors. Class sessions include faculty-led instruction and case studies, coaching sessions by industry specialists, expert guest lecturers, and interactive team meetings. Enrollment is by application only, and students are expected to participate in both quarters of the course. Visit http://biodesign.stanford.edu/programs/stanford-courses/biodesign-innovation.html to access the application, examples of past projects, and student testimonials. More information about Stanford Biodesign, which has led to the creation of more than 50 venture-backed healthcare companies and has helped hundreds of students launch health technology careers, can be found at http://biodesign.stanford.edu/.
Terms: Spr | Units: 4

PEDS 222: Beyond Health Care: the effects of social policies on health (HUMBIO 122)

Available evidence at the national and cross-country level linking social welfare interventions and health outcomes. If and how non-health programs and policies could have an impact on positive health outcomes. Evaluation of social programs and policies that buffer the negative health impact of economic instability and unemployment among adult workers and their children. Examination of safety nets, including public health insurance, income maintenance programs, and disability insurance. Enrollment limited to junior and seniors and graduate students or consent of the instructor. HUMBIO students must enroll in HUMBIO 122. Med/Graduate students must enroll in PEDS 222.
Terms: Aut | Units: 3
Instructors: ; Rodriguez, E. (PI)

PEDS 223: Human Rights and Global Health

Open to medical students, graduate students, and advanced undergraduates. Examines the newly emerging field of human rights and global health, beginning with the essential background into the field of human rights, and the recent emergence of health as a human right. Emphasis is on the pioneering work of Dr. Paul Farmer and Partners in Health and the challenge he and his organization have posed to the conventional wisdom about approaches to combating poor health and disease worldwide. Topics include the "big three" infectious diseases -- tuberculosis, malaria, and HIV/AIDS -- as well as emerging infectious diseases, clean water and sanitation, and malnutrition and famine.
Terms: Spr | Units: 3
Instructors: ; Patenaude, B. (PI)

PEDS 250: Social and Environmental Determinants of Health (HUMBIO 122H, PEDS 150)

Race, ethnicity, and socioeconomic status are just a few of the social determinants that contribute to health disparities. Apply a racial equity lens to drive a deeper understanding of how vulnerable populations are uniquely at risk for poorer health outcomes. Explore how where we live, work, learn, and play influences health status, and examine the processes through which social and environmental determinants adversely affect health and drive inequities across the lifespan. With experts from multiple sectors, this course will discuss innovative clinical, public health, policy, advocacy, and community engaged solutions to advance health equity. Explore the unique role of health professionals in addressing health inequities. HUMBIO students should enroll in HUMBIO 122H. Undergraduates may enroll in PEDS 150. Graduate/Med Students should enroll in PEDS 250. (Cardinal Course certified by the Haas Center).
Terms: Win | Units: 3

PUBLPOL 156: Health Care Policy and Reform (HUMBIO 122A)

Focuses on U.S. health care policy. Includes comparisons with health care policy in other countries and detailed examinations of Medicare, Medicaid, private insurance, the Affordable Care Act (ACA), and proposed reforms. Examines health policy efforts at state and local levels. The course includes sessions on effective memo writing as well as presentation and the politics of health policy and reform efforts. HUMBIO students must enroll in HUMBIO 122A. Graduate students must enroll in PUBLPOL 156. **Enrollment will be decided via application. Applications will open on Aug. 30 at 6:00 p.m. and close on Sept. 6 at 5 p.m. To apply, visit https://forms.gle/thzX6CYjvRvaz5Ra8 **
Terms: Aut | Units: 5 | UG Reqs: WAY-SI

PUBLPOL 238: Wise Interventions (PSYCH 138, PSYCH 238)

Classic and contemporary psychological interventions; the role of psychological factors in social reforms for social problems involving healthcare, the workplace, education, intergroup, relations, and the law. Topics include theories of intervention, the role of laboratory research, evaluation, and social policy.
Terms: Win | Units: 4
Instructors: ; Walton, G. (PI)

SOMGEN 207: Theories of Change in Global Health (INTLPOL 291, PUBLPOL 291)

Organizations dedicated to improving global health deploy various approaches ranging from efforts to improve economic conditions, health systems, and technology to policy change and advocacy. This course critically evaluates 15 common theories of change that underlay global health interventions. Students will review and discuss examples of both success and failure of each theory of change drawn from various disciplines. This seminar is appropriate for graduate students of any discipline who are interested in considering the range of approaches and their likely utility when considering a specific global health problem in a particular location. Upper-class undergraduates who have completed rigorous related coursework and who are willing to commit the preparatory time are welcome. Our discussions benefit greatly from diverse perspectives. Sign up for 3 unit credits to participate in the seminar or 4 units to participate in the seminar and complete a project that provides an opportunity to apply these ideas to a global health problem of your interest.
Terms: Win | Units: 3-4
Instructors: ; Luby, S. (PI)

SOMGEN 275: Leading Value Improvement in Health Care Delivery

Successful leaders on the journey to better care delivery methods with lower total spending inevitably face challenges. What confluence of attitudes, values, strategy, and events allows them to prevail? Contexts will include public policy, entrepreneurship and early stage investing, care delivery innovations, and health care system management to improve the value of care. Course faculty and guests will consist of nationally recognized leaders, innovators, and change agents. The course is open to any member of the Stanford community aspiring to lead value improvement in health care delivery including medical, MBA, law, and graduate students, as well as undergraduates, postdoctoral candidates, and medical center trainees. May be repeated for credit.
Terms: Aut | Units: 1 | Repeatable 4 times (up to 4 units total)

STEMREM 250: Regenerative Medicine Seminar Series

A forum for Stanford researchers to meet, hear about what is going on in Stem Cell Biology and Regenerative Medicine at Stanford, and spark collaborations. Topics include all areas of regenerative medicine, broadly defined, ranging from fundamental biological principles and basic science advances to novel applications in biotechnology, stem cell biology, and human disease.
Terms: Aut, Win, Spr | Units: 1 | Repeatable 5 times (up to 5 units total)
Instructors: ; Spangrude, G. (PI)

STRAMGT 364: Health Information Technology and Strategy

Health Information technology was intended to help reduce cost and improve the quality of health care services. To date, this is little evidence that this goal has been achieved. This course is designed to explore economic frameworks that can help us to understand how health IT can achieve it's intended goals. These frameworks build from general business and economic models used successfully in other industries. The course will utilize both business cases and lecture to prepare students to propose potential novel applications of health information technology solutions. Each student will have a team-based final project.
Terms: Aut | Units: 3
© Stanford University | Terms of Use | Copyright Complaints